Metraipolis › archive › dc_ff4ec83e05e0

Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative — Europe PMC PMID:42198248

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198248
DOI
10.3390/pharmaceutics18050554
License (as archived)
solo-consultazione
Archived
2026-11-03T00:26:50.344Z
SHA-256 of the archived text
e527c2f6264d93c179fa9af2749d113881d44c123536f9c4cd5cd2ef959c3776
Stable URL of this page
https://metraipolis.com/documento/dc_ff4ec83e05e0

How to cite

Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative — Europe PMC PMID:42198248 — Europe PMC (en), https://europepmc.org/article/MED/42198248 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff4ec83e05e0 (Metraipolis archive dc_ff4ec83e05e0, sha256 e527c2f6264d93c179fa9af2749d113881d44c123536f9c4cd5cd2ef959c3776)
BibTeX
@misc{dcff4ec83e05e0,
  title = {Targeting Lysyl Oxidase-like 2: A Therapeutic Strategy for Idiopathic Pulmonary Fibrosis with a Novel Indolizine Derivative — Europe PMC PMID:42198248},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198248},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff4ec83e05e0; sha256 e527c2f6264d93c179fa9af2749d113881d44c123536f9c4cd5cd2ef959c3776},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198248. Agents can read the archived copy with the MCP tool read_document.